NFKB1 and osteoporosis: We demonstrate that puerarin decreases bone mass loss by inhibiting osteoclast differentiation and activity through reduction of ROS levels and ROS-dependent MAPK and NF-κB signaling pathways in the OVX-induced osteoporosis model mice.